Mayinglong Pharmaceutical Group Co Ltd (600993) — Cash Flow-to-Debt Ratio
Mayinglong Pharmaceutical Group Co Ltd (600993) has a Cash Flow-to-Debt Ratio of 0.15x as of September 2025, meaning its operating cash flow of CN¥139.20 Million could theoretically repay 0% of its total liabilities (CN¥909.82 Million) in one year. See Mayinglong Pharmaceutical Group Co Ltd (600993) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Mayinglong Pharmaceutical Group Co Ltd Cash Flow-to-Debt Ratio (2003–2025)
Historical debt coverage capacity for Mayinglong Pharmaceutical Group Co Ltd across 23 annual periods. Also explore 600993 net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Mayinglong Pharmaceutical Group Co Ltd (2003–2025)
Year-by-year debt coverage analysis for Mayinglong Pharmaceutical Group Co Ltd. For market capitalisation and broader financial context, see 600993 market cap.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.65x | CN¥600.44 Million | CN¥921.49 Million | ▲ +28.4% |
| 2024 | 0.51x | CN¥497.61 Million | CN¥980.66 Million | ▼ -19.4% |
| 2023 | 0.63x | CN¥604.07 Million | CN¥959.62 Million | ▲ +164.9% |
| 2022 | 0.24x | CN¥341.85 Million | CN¥1.44 Billion | ▼ -67.7% |
| 2021 | 0.73x | CN¥597.17 Million | CN¥812.72 Million | ▲ +138.9% |
| 2020 | 0.31x | CN¥282.99 Million | CN¥919.89 Million | ▼ -59.3% |
| 2019 | 0.76x | CN¥491.58 Million | CN¥650.49 Million | ▲ +40.9% |
| 2018 | 0.54x | CN¥308.24 Million | CN¥574.67 Million | ▼ -27.3% |
| 2017 | 0.74x | CN¥356.17 Million | CN¥482.99 Million | ▲ +47.7% |
| 2016 | 0.50x | CN¥239.60 Million | CN¥479.88 Million | ▲ +42.9% |
| 2015 | 0.35x | CN¥182.85 Million | CN¥523.31 Million | ▲ +52.3% |
| 2014 | 0.23x | CN¥111.67 Million | CN¥486.89 Million | ▼ -18.6% |
| 2013 | 0.28x | CN¥129.94 Million | CN¥461.22 Million | ▼ -31.8% |
| 2012 | 0.41x | CN¥169.25 Million | CN¥409.56 Million | ▲ +85.2% |
| 2011 | 0.22x | CN¥75.37 Million | CN¥337.70 Million | ▲ +728.6% |
| 2010 | -0.04x | CN¥-11.42 Million | CN¥321.68 Million | ▼ -106.3% |
| 2009 | 0.56x | CN¥216.11 Million | CN¥384.11 Million | ▲ +59.9% |
| 2008 | 0.35x | CN¥102.59 Million | CN¥291.46 Million | ▲ +1194.6% |
| 2007 | 0.03x | CN¥6.49 Million | CN¥238.53 Million | ▼ -91.0% |
| 2006 | 0.30x | CN¥75.27 Million | CN¥250.53 Million | ▼ -9.8% |
| 2005 | 0.33x | CN¥58.43 Million | CN¥175.45 Million | ▼ -19.6% |
| 2004 | 0.41x | CN¥54.19 Million | CN¥130.74 Million | ▼ -16.1% |
| 2003 | 0.49x | CN¥67.52 Million | CN¥136.61 Million | — |